These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21198230)

  • 1. Drug use during pregnancy: validating the Drug Abuse Screening Test against physiological measures.
    Grekin ER; Svikis DS; Lam P; Connors V; Lebreton JM; Streiner DL; Smith C; Ondersma SJ
    Psychol Addict Behav; 2010 Dec; 24(4):719-23. PubMed ID: 21198230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and preliminary validation of an indirect screener for drug use in the perinatal period.
    Ondersma SJ; Svikis DS; LeBreton JM; Streiner DL; Grekin ER; Lam PK; Connors-Burge V
    Addiction; 2012 Dec; 107(12):2099-106. PubMed ID: 22882721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Drug Abuse Screening Test (DAST-10): A study on illicit drug use among Chinese pregnant women.
    Lam LP; Leung WC; Ip P; Chow CB; Chan MF; Ng JW; Sing C; Lam YH; Mak WL; Chow KM; Chin RK
    Sci Rep; 2015 Jun; 5():11420. PubMed ID: 26091290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of five self-report screening instruments for substance use in pregnancy.
    Ondersma SJ; Chang G; Blake-Lamb T; Gilstad-Hayden K; Orav J; Beatty JR; Goyert GL; Yonkers KA
    Addiction; 2019 Sep; 114(9):1683-1693. PubMed ID: 31216102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin K; Koszowski B; Mark K
    BMJ Open; 2018 Feb; 8(2):e020248. PubMed ID: 29455170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.
    Oga EA; Mark K; Peters EN; Coleman-Cowger VH
    J Addict Med; 2020; 14(5):423-430. PubMed ID: 32032210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of a two-item Drug Abuse Screening Test (DAST-2).
    Tiet QQ; Leyva YE; Moos RH; Smith B
    Addict Behav; 2017 Nov; 74():112-117. PubMed ID: 28609724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening illicit substance use in college students: The Chinese version of the Drug Abuse Screening Test.
    Chen YT; Chang JC; Lee CS
    Drug Alcohol Depend; 2020 Oct; 215():108184. PubMed ID: 32763780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mothers of young children for substance abuse.
    Kemper KJ; Greteman A; Bennett E; Babonis TR
    J Dev Behav Pediatr; 1993 Oct; 14(5):308-12. PubMed ID: 8254061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Drug Abuse Screening Test preserves its excellent psychometric properties in psychiatric patients evaluated in an emergency setting.
    Giguère CÉ; Potvin S;
    Addict Behav; 2017 Jan; 64():165-170. PubMed ID: 27614056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of substances abuse in burn patients by using drug abuse screening test.
    Salehi SH; As'adi K; Musavi J; Ahrari F; Nemazi P; Kamranfar B; Gaseminegad K; Faramarzi S; Shoar S
    Acta Med Iran; 2012; 50(4):257-64. PubMed ID: 22592576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Turkish versions of the Drug Use Disorders Identification Test (DUDIT) and the Drug Abuse Screening Test (DAST-10) in the prison setting.
    Evren C; Ogel K; Evren B; Bozkurt M
    J Psychoactive Drugs; 2014; 46(2):140-6. PubMed ID: 25052790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for alcohol and drug use during pregnancy.
    Chang G
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):205-12. PubMed ID: 24845485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR; Northrup TF; Villarreal YR; Berens PD; Blackwell S; Bunag T; Stotts AL
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India.
    Carey KB; Carey MP; Chandra PS
    J Clin Psychiatry; 2003 Jul; 64(7):767-74. PubMed ID: 12934976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Three Screening Tools for Prenatal Substance Use.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin KE; Koszowski B; Mark K
    Obstet Gynecol; 2019 May; 133(5):952-961. PubMed ID: 30969217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the drug abuse screening test for adolescents (DAST-A).
    Martino S; Grilo CM; Fehon DC
    Addict Behav; 2000; 25(1):57-70. PubMed ID: 10708319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Substance Use Disorders Following Traumatic Brain Injury: Examining the Validity of the AUDIT and the DAST.
    Bryce S; Spitz G; Ponsford J
    J Head Trauma Rehabil; 2015; 30(5):E40-8. PubMed ID: 25310295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The substance abuse subtle screening inventory minimizes the need for toxicology screening of prenatal patients.
    Horrigan TJ; Piazza N
    J Subst Abuse Treat; 1999 Oct; 17(3):243-7. PubMed ID: 10531631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM; Welch RA
    Clin Perinatol; 1991 Sep; 18(3):629-45. PubMed ID: 1934859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.